doi: 10.3389/fncel.2025.1601366 Received 27 March 2025 Accepted 10 June 2025 Published 04 July 2025 Volume 19 - 2025 Edited by Marco Cambiaghi, University of Verona, Italy Reviewed by Enoch Luis, National Council of Science and Technology (CONACYT), Mexico Mingzi Zhang, University of Southern California, United States Updates Copyright 2025 Bessetti and Litwa
From a strict drug-drug interaction (DDI) database standpoint, neither Lexicomp, Micromedex, nor the FDA's drug interaction table lists an ipamorelin-apixaban interaction
Shorter faster treatment option
Sequence: MFPAMPLSSL FVNGPRTLCG AELVDALQFV CGDRGFYFNK PTGYGSSSRR APQTGIVDEC CFRSCDLRRL EMYCAPLKPA KSA
Key Features: Range of Flavors: Enjoy the refreshing taste of our carefully crafted flavors, designed to make every sip as enjoyable as your workout
Not evaluated or approved by the FDA